Daxxify has received its U.S. Food and Drug Administration (FDA) approval in September of 2022, and the early reviews are glowing. But does it genuinely have a shot at the unthinkable — the dethronement of BOTOX? Or will BOTOX’s longevity, market share, and predilection among providers ensure its safety? Only time will tell. But until then, let’s discover how the two contendants fare against each other!